Financials data is unavailable for this security.
View more
Year on year Consun Pharmaceutical Group Ltd grew revenues 10.71% from 2.34bn to 2.59bn while net income improved 14.88% from 682.91m to 784.53m.
Gross margin | 74.22% |
---|---|
Net profit margin | 30.66% |
Operating margin | 34.59% |
Return on assets | 15.97% |
---|---|
Return on equity | 23.91% |
Return on investment | 23.24% |
More ▼
Cash flow in CNYView more
In 2023, Consun Pharmaceutical Group Ltd increased its cash reserves by 12.17%, or 298.09m. The company earned 818.97m from its operations for a Cash Flow Margin of 31.62%. In addition the company used 231.77m on investing activities and also paid 280.10m in financing cash flows.
Cash flow per share | 1.24 |
---|---|
Price/Cash flow per share | 7.29 |
Book value per share | 4.77 |
---|---|
Tangible book value per share | 4.42 |
More ▼
Balance sheet in CNYView more
Current ratio | 3.06 |
---|---|
Quick ratio | 2.80 |
Total debt/total equity | 0.1393 |
---|---|
Total debt/total capital | 0.1144 |
More ▼
Growth rates in CNY
SmartText is unavailable
Div yield(5 year avg) | 7.68% |
---|---|
Div growth rate (5 year) | 18.43% |
Payout ratio (TTM) | 53.59% |
EPS growth(5 years) | 13.12 |
---|---|
EPS (TTM) vs TTM 1 year ago | 12.05 |
More ▼